Manzo Pharmaceuticals

(OTC) MNZO

Current Price$0.00

Market Cap$937,500

Since IPO (1992)-100%

5 Year-80%

1 Year+0%

1 Month+0%

Manzo Pharmaceuticals Financials at a Glance

Market Cap

$937,500

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

14.40 (High)

Dividend

$0.00

Beta (Volatility)

14.40 (High)

Price

$0.00

Volume

2,422,308

Open

$0.00

Price

$0.00

Volume

2,422,308

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

14.40 (High)

Price

$0.00

Volume

2,422,308

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

MNZO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Manzo Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Milford, PA 18337, US

MNZO Financials

Key Financial Metrics (TTM)

Gross Margin

39%

Operating Margin

39%

Net Income Margin

-18%

Return on Equity

Return on Capital

Return on Assets

-19%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$937.50K

Shares Outstanding

9.37B

Volume

2.42M

Avg. Volume

55.09K

Financials (TTM)

Gross Profit

$793.00

Operating Income

$793.00

EBITDA

$793.00

Operating Cash Flow

$1.11M

Capital Expenditure

$2.26K

Free Cash Flow

$1.11M

Cash & ST Invst.

$12.31K

Total Debt

$11.09K

Manzo Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2005YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$937.50K

N/A

Market Cap/Employee

$78.13K

N/A

Employees

N/A

Net Income

$1.23M

N/A

EBITDA

$27.89K

N/A

Quarterly Fundamentals

Name

Q3 2005YOY CHG

Net Cash

$5.11M

N/A

Accounts Receivable

$2.68M

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$5.12M

N/A

Return on Assets

-18.84%

N/A

Return on Invested Capital

0.39%

N/A

Free Cash Flow

$608.34K

N/A

Operating Cash Flow

$608.34K

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

JADAJade Art Group Inc.

JADAJade Art Group Inc.$0.00+0.00%

VNTAVentana Biotech, Inc.

VNTAVentana Biotech, Inc.$0.04+0.00%

LTUSLotus Pharmaceuticals, Inc.

LTUSLotus Pharmaceuticals, Inc.$0.00+0.00%

AWWIAlpha Wastewater, Inc.

AWWIAlpha Wastewater, Inc.$0.00+0.00%

IKTOiTokk, Inc.

IKTOiTokk, Inc.$0.00+0.00%

BFYWBetter For You Wellness, Inc.

BFYWBetter For You Wellness, Inc.$0.00+0.00%

OHCSOptimus Healthcare Services, Inc.

OHCSOptimus Healthcare Services, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

Questions About MNZO

What is the current price of Manzo Pharmaceuticals?

Manzo Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Manzo Pharmaceuticals?

Over the past 52 weeks, Manzo Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does Manzo Pharmaceuticals have?

Manzo Pharmaceuticals total debt is unavailable.

How much cash does Manzo Pharmaceuticals have on hand?

Manzo Pharmaceuticals does not have cash on hand data available.

What is Manzo Pharmaceuticals’s dividend yield?

Manzo Pharmaceuticals does not currently have a dividend yield.

Manzo Pharmaceuticals

Manzo Pharmaceuticals Financials at a Glance

MNZO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Manzo Pharmaceuticals

MNZO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Manzo Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MNZO

What is the current price of Manzo Pharmaceuticals?

What is the 52-week range for Manzo Pharmaceuticals?

How much debt does Manzo Pharmaceuticals have?

How much cash does Manzo Pharmaceuticals have on hand?

What is Manzo Pharmaceuticals’s dividend yield?

Premium Investing Services